| Financial Year |
March 31 2023 |
| Monetary Funds |
202,443,242.70 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
209,615,008.54 |
| Advances to Suppliers |
1,883,474.28 |
| Other Receivables |
5,488,945.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
511,914,655.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,433,445.24 |
| Total Current Assets |
1,460,337,301.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
195,860,934.99 |
| Investment Properties |
-- |
| Fixed Assetes |
289,473,174.32 |
| Under-construction Projects |
20,632,401.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
58,436,099.01 |
| R&D expenses |
-- |
| Goodwill |
7,744,546.19 |
| Long-Term Deferred and Prepaid Expenses |
631,147.21 |
| Deferred Income Tax Assets |
35,020,861.55 |
| Other Non-Current Assets |
102,165,836.72 |
| Sub-Total of Non-Current Assets |
740,205,759.51 |
| Total Assets |
2,200,543,060.57 |
| Short-Term Loans |
585,592,897.37 |
| Trading Financial liabilities |
-- |
| Notes Payable |
157,628,125.09 |
| Accounts Payable |
343,231,149.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,518,965.96 |
| Taxes Payable |
7,073,750.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
22,333,835.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
131,584.35 |
| Other Current Liabilities |
15,737,718.18 |
| Sub-Total of Current Liabilities |
1,295,961,740.22 |
| Long-term Loans |
30,015,082.39 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
30,125,675.21 |
| Total Liabilities |
1,326,087,415.43 |
| Paid-In Capital(Or Share Stock) |
110,530,936.00 |
| Capital Surplus |
540,172,212.81 |
| Surplus Reserve |
36,418,899.52 |
| LESS:Treasury Stock |
7,497,221.00 |
| Undistributed Profits |
196,191,899.32 |
| Minority Stockholder's Interest |
-1,388,848.56 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
875,844,493.70 |
| Owner's Equity（Stockholder's Equity） |
874,455,645.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,200,543,060.57 |
